Objective: To explore the management model of clinical pharmacists' participation in chronic obstructive pulmonary disease (COPD) patients' drug treatment, so as to provide reference for pharmacists' participation in chronic disease management. Methods: 30 patients with COPD admitted to the department of respiratory medicine of the first affiliated hospital of jinan university who met the inclusion criteria were selected. The patients were followed up after safe medication intervention management and stable discharge with the participation of clinical pharmacists and cooperation with doctors. mMRC, CAT, MNA and SGRQ scores before and after the intervention were compared. Results: After the intervention in this model, the results before intervention and after the first and second follow-up showed that the mMRC score, CAT score and SGRQ score were all decreased, while the MNA score was increased, the difference was statistically significant (p<0.01). Conclusion: the participation of clinical pharmacists in COPD management can improve the respiratory symptoms of patients, reduce the risk of acute exacerbation, and improve the quality of life of the patients under management to some extent.
| Published in | Science Development (Volume 4, Issue 4) |
| DOI | 10.11648/j.scidev.20230404.12 |
| Page(s) | 71-73 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2023. Published by Science Publishing Group |
COPD, Clinical Pharmacist, Management
| [1] | Han Huijuan, Wang Xueyan, Yin Shuli. Effect of KAP model health education combined with comprehensive respiratory function exercise on patients with COPD [J]. Journal of Qilu Nursing, 2002, 28(7): 24-27. |
| [2] | Zhou Y. Design and application of Internet + chronic disease management system [J]. Healthcare Equipment, 2018, 39(5): 55-58. (in Chinese) |
| [3] | Wang Xuanwu. Process design and system implementation of chronic disease management for the elderly in CK Health Management Company [D]. Lanzhou: Lanzhou Jiaotong University, 2018: 9-11. |
| [4] | WANG Yao, Pan Xudong, Wang Ling. Current situation and implications of chronic COPD management in the elderly in foreign countries [J]. Chinese Journal of Gerontology, 2013, (1): 236-239. |
| [5] | Zhang Minfen, Wang Jing. Discussion on the importance of chronic disease management in primary hospital for elderly patients [J]. Journal of Chinese Medicine Administration, 2019, 27(2): 216-217. (in Chinese) |
| [6] | Fan L. The management of hypertension combined with asthenia in the elderly remains a long and arduous task [J]. Chinese Journal of Geriatric Multi-organ Diseases, 2018, 17(5): 321-323. (in Chinese) |
| [7] | Wan Qiu, Song Shuangshuang, He Ting, et al. Clinical application of drugs for chronic obstructive pulmonary disease combined with cardiovascular disease [J]. Chinese Pharmacy, 2019, 30(16): 2289-2293. |
| [8] | ZHENG Shanshan, Zhang Longhua, Chen Hongxia, Pan Ying, Lin Yong, Lei Xiaohong. Correlation analysis of mMRC grade and diaphragm activity after thoracoscopic radical lung cancer surgery [J]. Journal of Rare and Rare Diseases, 2019, 30(09): 41-42. |
| [9] | Zhang Lian-feng, Wang Qiao-xian. Effect of ipratropium bromide combined with budesonide aerosol inhalation on mMRC score and pulmonary function in patients with acute exacerbation of COPD [J]. Modern Diagnosis and Therapy, 2019, 34(04): 541-543. |
| [10] | Atsushi Hayata, Yoshiaki Minakata, Kazuto Matsunaga, et al. Differences in physical activity according to mMRC grade in patients with COPD [J]. International Journal of COPD, 2018, 9(15): 2203-2208. |
| [11] | Folch Ayora A, Macia-Soler L, Orts-Cortés MI, et al. Comparative analysis of the psychometric parameters of two quality-of-life questionnaires the SGRQ and CAT, in the assessment of patients with COPD exacerbations during hospitalization: a multicenter study [J]. Chron Respir Dis, 2018, 15(4): 374-383. |
| [12] | Correlation between FEV1%pred and SGRQ, mMRC and CAT scores in patients with COPD [J]. International Respiratory Journal, 21, 41(19): 1493-1499. |
| [13] | ZHONG Yanjun, Ma Yiming, Chen Yan. Clinical application of COPD screening questionnaire [J]. Chinese Journal of Health Management, 2019, 16(7): 497-501. (in Chinese) |
| [14] | Chen Haijie, Chen Yahong. Actively optimizing the management of chronic obstructive pulmonary disease to reduce the risk of cardiopulmonary events [J]. Journal of Tuberculosis and Pulmonary Diseases, 2023, v. 4(05). |
| [15] | Shao Lijie, rich and solid. The management of chronic obstructive pulmonary disease in basic public hospitals needs medical and preventive integration [J]. Practical Geriatrics, 2023, v. 37(07): 650-653. |
APA Style
Huan, L., KunYu, H. (2023). A Preliminary Study of Clinical Pharmacists' Participation in Drug Therapy Management of COPD Patients. Science Development, 4(4), 71-73. https://doi.org/10.11648/j.scidev.20230404.12
ACS Style
Huan, L.; KunYu, H. A Preliminary Study of Clinical Pharmacists' Participation in Drug Therapy Management of COPD Patients. Sci. Dev. 2023, 4(4), 71-73. doi: 10.11648/j.scidev.20230404.12
AMA Style
Huan L, KunYu H. A Preliminary Study of Clinical Pharmacists' Participation in Drug Therapy Management of COPD Patients. Sci Dev. 2023;4(4):71-73. doi: 10.11648/j.scidev.20230404.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.scidev.20230404.12,
author = {Li Huan and Huang KunYu},
title = {A Preliminary Study of Clinical Pharmacists' Participation in Drug Therapy Management of COPD Patients},
journal = {Science Development},
volume = {4},
number = {4},
pages = {71-73},
doi = {10.11648/j.scidev.20230404.12},
url = {https://doi.org/10.11648/j.scidev.20230404.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.scidev.20230404.12},
abstract = {Objective: To explore the management model of clinical pharmacists' participation in chronic obstructive pulmonary disease (COPD) patients' drug treatment, so as to provide reference for pharmacists' participation in chronic disease management. Methods: 30 patients with COPD admitted to the department of respiratory medicine of the first affiliated hospital of jinan university who met the inclusion criteria were selected. The patients were followed up after safe medication intervention management and stable discharge with the participation of clinical pharmacists and cooperation with doctors. mMRC, CAT, MNA and SGRQ scores before and after the intervention were compared. Results: After the intervention in this model, the results before intervention and after the first and second follow-up showed that the mMRC score, CAT score and SGRQ score were all decreased, while the MNA score was increased, the difference was statistically significant (p<0.01). Conclusion: the participation of clinical pharmacists in COPD management can improve the respiratory symptoms of patients, reduce the risk of acute exacerbation, and improve the quality of life of the patients under management to some extent.
},
year = {2023}
}
TY - JOUR T1 - A Preliminary Study of Clinical Pharmacists' Participation in Drug Therapy Management of COPD Patients AU - Li Huan AU - Huang KunYu Y1 - 2023/12/18 PY - 2023 N1 - https://doi.org/10.11648/j.scidev.20230404.12 DO - 10.11648/j.scidev.20230404.12 T2 - Science Development JF - Science Development JO - Science Development SP - 71 EP - 73 PB - Science Publishing Group SN - 2994-7154 UR - https://doi.org/10.11648/j.scidev.20230404.12 AB - Objective: To explore the management model of clinical pharmacists' participation in chronic obstructive pulmonary disease (COPD) patients' drug treatment, so as to provide reference for pharmacists' participation in chronic disease management. Methods: 30 patients with COPD admitted to the department of respiratory medicine of the first affiliated hospital of jinan university who met the inclusion criteria were selected. The patients were followed up after safe medication intervention management and stable discharge with the participation of clinical pharmacists and cooperation with doctors. mMRC, CAT, MNA and SGRQ scores before and after the intervention were compared. Results: After the intervention in this model, the results before intervention and after the first and second follow-up showed that the mMRC score, CAT score and SGRQ score were all decreased, while the MNA score was increased, the difference was statistically significant (p<0.01). Conclusion: the participation of clinical pharmacists in COPD management can improve the respiratory symptoms of patients, reduce the risk of acute exacerbation, and improve the quality of life of the patients under management to some extent. VL - 4 IS - 4 ER -
Department of Pharmacy, The First Affiliated Hospital of Jinan University, Guangzhou, China
Department of Pharmacy, Shenshan Central Hospital, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Shantou, China
Information